Bird flu is one mutation from serious risk to humans – how prepared is the UK?

Bird flu: Biosecurity experts globally are monitoring a mink farm in rural Utah where animals raised for fur are dying from bird flu. Considered one of the most likely causes of the next global pathogen, the presence of the virus in minks elevates its threat status according to Professor Wendy Barclay, a virologist at Imperial College London, who noted that.

Bird flu, USA News (Utah): Biosecurity experts globally are monitoring a mink farm in rural Utah where animals raised for fur are dying from bird flu. Considered one of the most likely causes of the next global pathogen, the presence of the virus in minks elevates its threat status according to Professor Wendy Barclay, a virologist at Imperial College London, who noted that mink respiratory tracts resemble those of humans.

While historical influenza pandemics include four major events since the First World War, the current strain primarily circulates in wild birds and has occasionally impacted poultry and dairy farms in the US without causing cattle culls. Although farm worker infections have generally been mild with limited human-to-human transmission, the prolonged Utah outbreak has raised concern over potential mutations and reassortment.

The Risks of Mammalian Incubation

Professor Mark Woolhouse of the University of Edinburgh notes that respiratory cells in minks mirror human biology. Prior research indicates single genetic changes could enhance transmission to humans, while minks can also act as incubators allowing human and bird flu strains to swap genes. Dr Simon Williams of Swansea University highlighted the autumn timing as an additional risk factor for farm workers concurrently carrying seasonal flu.

UK Preparedness and Response

The UK Health Security Agency stated it maintains established detection systems and stands ready to respond, though it declined to comment on specific measures regarding the mink outbreak. The Department of Health and Social Care periodically conducts pandemic exercises, while the NHS maintains stockpiled personal protective equipment valued at £25m as of 2025.

Experts remain divided on vaccine timelines. Standard manufacturing methods would require six months to produce tailored vaccines, whereas mRNA technology could enable production within six weeks. Dr Simon Clarke of the University of Reading noted existing seasonal vaccines would offer minimal cross-protection against a novel pandemic strain. Meanwhile, Professor Woolhouse advocates for practical stress-testing of rapid diagnostic tests rather than relying solely on paper exercises.

Felix Reeves

Felix Reeves is the Digital Motoring Editor at USA News after joining in July 2023. He previously worked as a Motoring News Reporter at the Express.

If you have a story you want to share, email felix.reeves@icifmede.com or motoring@icifmede.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Sports

Explore USA News